Results 81 to 90 of about 1,058 (155)
Influence of therapy chronic heart failure of functional class III on regulatory adaptive status
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD). All them administered of complex therapy (Quinapril, Torasemide, Spironolactone).
E. S. Rokotyanskaya
doaj
100 patients with CHF FC III against the background of ischemic heart disease (IHD) and/or stage III hypertensive disease (HD) who received complex therapy (quinapril, torasemide, spironolactone) took part in the research.
E. S. Rokotyanskaya
doaj
Background: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam +6 more
doaj +1 more source
Overview of the clinical development of quinapril
Quinapril hydrochloride is the newest member of a family of angiotensin-converting enzyme (ACE) inhibitors. On completion of laboratory and animal studies, a clinical program was initiated to evaluate the antihypertensive and other properties of the drug in human subjects.
openaire +2 more sources
Objetivo: Valorar el comportamiento de la tensión arterial en un grupo de mujeres con hipertensión arterial esencial- estadio II tratadas con guinapril, un inhibidor de la enzima convertidora de angiotensina. Métodos: se realizó un estudio epidemiológico
Mario E. Garcés Ferrer +2 more
doaj
Safety of Drugs in Breastfeeding Women With CKD
Introduction: The benefits of breastfeeding are widely recognized. Because of lack of evidence, women may forego breastfeeding or decline treatments that impact long-term renal survival.
Paula Parnizari +2 more
doaj +1 more source
[The Study Group of Quinapril in Arterial Hypertension. The Steering Committee]
The efficacy and safety of the treatment of arterial hypertension with the ACE-inhibitor quinapril, were evaluated in a multicentre study conducted in Italy.
Brusca A +9 more
core
Adolescent type 1 Diabetes cardio-renal Intervention Trial (AdDIT)
Background The prognosis for young people diagnosed with diabetes during childhood remains poor and this is mainly related to the long-term risk of developing vascular complications.
doaj +1 more source
The effect of quinapril and nifedipine on platelet aggregation, vascular endothelial function and coagulation system activity, was compared in a parallel-group, investigator-blind study carried out on patients with mild to moderate hypertension but no ...
Islim, FI +5 more
core +1 more source
Adverse event of ACE inhibitors: A descriptive analysis of FAERS data
Background and objective: Angiotensin-converting enzyme inhibitors are first-line therapies for hypertension and related cardiovascular and renal conditions. The study aimed to characterize the adverse event profile of ACE inhibitors using the U.S.
Nehad Jaser Ahmed
doaj +1 more source

